Somatropin biosimilar (Cristalia)

生长激素生物类似药（Cristalia）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSomatropin biosimilar (Cristalia)

Drug Alias NameSomatropin Cristalia生长激素生物仿制药（Cristalia）Somatropine (Cristalia)r-hGH CristaliaSomatropinum (Cristalia) +[6]

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar

Mechanisms of ActionGrowth hormone receptor agonists

TargetsGrowth hormone receptor

Therapy Area/IndicationsGrowth hormone deficiency

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCristalia

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCristalia

Active IndicationsN/A

Inactive IndicationsGrowth hormone deficiency

ATC CodeH01AC01